With GLP-1 generics making debut, doctors warn of ocular risks | Bengaluru News
Bengaluru: A 60-year-old woman with poorly controlled diabetes was started on a glucagon-like peptide (GLP)-1 drug to improve glycaemic control and aid weight loss. While she initially responded well, she developed sudden vision loss after eight to nine months and was diagnosed with non-arteritic anterior ischaemic optic neuropathy (NAION), also known as eye stroke.GLP-1 drugs,…
